Forensic Analysis · Technology / Software · as of Jun 28, 2026
SOPHiA GENETICS SA (SOPH)
A forensic read on SOPHiA GENETICS SA built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Clean
Earnings quality
1
Forensic signals
-140.6%
ROE
$413M
Market cap
SOPHiA GENETICS SA earns a D (Weak — demands caution) forensic quality grade. 1 forensic signal was flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-323%Return on invested capital. Return on invested capital is -323% and slipping from -69% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
Key fundamentals
Return on Equity-167.6%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on SOPHiA GENETICS SA:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about SOPH's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown
🔒Peer comparison + filing-change monitoring & alerts
No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Jun 28, 2026. Forensic signals flag probability, not certainty.